JPMorgan Chase & Co’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16
| Closed | -$99 | – | 6292 |
|
|
2025
Q1 | $99 | Sell |
16
-2
| -11% | -$12 | ﹤0.01% | 5997 |
|
|
2024
Q4 | $88 | Hold |
18
| – | – | ﹤0.01% | 5973 |
|
|
2024
Q3 | $91 | Buy |
+18
| New | +$91 | ﹤0.01% | 5943 |
|
|
2022
Q2 | – | Sell |
-14,185
| Closed | -$300K | – | 5655 |
|
|
2022
Q1 | $300K | Sell |
14,185
-335
| -2% | -$7.09K | ﹤0.01% | 4240 |
|
|
2021
Q4 | $421K | Sell |
14,520
-530
| -4% | -$15.4K | ﹤0.01% | 4165 |
|
|
2021
Q3 | $1.47M | Sell |
15,050
-3,662
| -20% | -$358K | ﹤0.01% | 3367 |
|
|
2021
Q2 | $2.44M | Buy |
18,712
+763
| +4% | +$99.3K | ﹤0.01% | 3105 |
|
|
2021
Q1 | $3.24M | Buy |
+17,949
| New | +$3.24M | ﹤0.01% | 2935 |
|